Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. - Wikidata - awgldk - TriplyDB

Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

http://www.wikidata.org/entity/Q51994063

about

A novel approach to minimize false discovery rate in genome-wide data analysis.Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure.Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium.Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.Rodent models of heart failure: an updated review.Matrix metalloproteinases are involved in cardiovascular diseases.Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.A role of matrix metalloproteinase-8 in atherosclerosis.Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study.Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations.Inhibition of gelatinase B (matrix metalloprotease-9) activity reduces cellular inflammation and restores function of transplanted pancreatic islets.Acute aortocaval fistula: role of low perfusion pressure and subendocardial remodeling on left ventricular function.Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets.Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia.

P2860

Q30763401-73673CC6-9BC9-4688-9036-BBEBCC46001F Q34066697-979A3B21-C4A5-4039-BD6D-6178038AD69E Q35590019-F368DEBD-7AC7-447F-B57B-1A367717EDCE Q35737545-41DA38CD-26AB-407D-8488-B65136201E3A Q36042371-29FC14EB-8013-4D2B-9F88-1183E79A9F3C Q37090568-4FB95DCC-A431-4FC7-A4FD-832E0A646CC2 Q37397232-7D7BDBEA-0B4A-4821-B1BC-161C4BDD3B06 Q37406326-783FB3F9-3CB5-4E0D-A445-25959A4768BF Q37705626-D62FA82E-E6F4-4C89-A743-9364217ECDD9 Q37996857-D453983D-14F7-44C4-B13C-224779AF3D93 Q38224193-78F835F9-4D78-4893-9D92-5338F2EB55DB Q39474625-583C54E7-48EB-433D-9437-9745BD43ABB9 Q40000765-F8E81292-9E8F-4203-8402-6CF662A49DDC Q40158928-3C35EDD1-F9BC-4503-B088-CA019EC6EB31 Q41230502-A39E4310-3CFC-42CF-B9B4-CFA93C73D292 Q42245588-90716CEC-69D8-4F09-B25F-FBE95A1FD5F3 Q45838172-527B0B16-3A5B-4DCA-93C5-CA38430E3D91 Q46003956-A1FA6AE9-2BF3-488B-946F-2DEC4449C895 Q50317765-7D4E2D06-9F8A-4C55-B380-CDAC28CC9290 Q50320452-5C95794D-C826-47CF-83FB-0E9ACDD14E04

P2860

Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

http://www.wikidata.org/entity/Q51994063

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Inhibition of matrix metallopr ...... a rat model of heart failure.

@en

Inhibition of matrix metallopr ...... a rat model of heart failure.

@nl

type

label

Inhibition of matrix metallopr ...... a rat model of heart failure.

@en

Inhibition of matrix metallopr ...... a rat model of heart failure.

@nl

prefLabel

Inhibition of matrix metallopr ...... a rat model of heart failure.

@en

Inhibition of matrix metallopr ...... a rat model of heart failure.

@nl

P1433

Q51994063-2269AC5F-9675-41F8-AD93-49988F5E5DFB

P1476

Q51994063-EF03F87A-C558-4D8B-8BF0-342144BABDB8

P2093

Q51994063-1315FC6F-8D8A-4D5E-8299-E3F05677D5C7

Q51994063-430BBA84-B010-4E8E-BE6F-6F0ECEBC7268

P2860

Q51994063-0AA34C14-EEDE-465E-91B3-8EBE8C4357D7

Q51994063-0AF9A7AA-EC6A-4E28-A886-A5BB517DDEA7

Q51994063-0F858683-AA84-40A7-9C13-5227A2663402

Q51994063-1E099927-709C-4E51-83A6-4811992E4CB1

Q51994063-2D91B72D-26A9-45D3-8EC5-6A058431DB41

Q51994063-2EFCC99F-BD38-469F-96A2-4C707C6B1429

Q51994063-3A014505-D35C-4F56-A869-E6B5F52A29AB

Q51994063-4227401B-5F71-4B52-BDBA-755200254EF7

Q51994063-6894CCF0-2664-40BA-8090-99520D58CCD4

Q51994063-6E013777-FC0F-4635-A980-0F85E8CD7A49

P304

Q51994063-63429F07-CEEF-43FC-8E9F-52F4F3B19089

P31

Q51994063-319265C5-DF5B-4AFF-9444-60CAA6955EF0

P356

Q51994063-BCEC0A87-1B5D-4C98-A4E8-797282B05EDB

P433

Q51994063-0F3F7FEA-43AC-41E7-92D7-B6C09E25C880

P478

Q51994063-41099789-200F-4AEA-AA99-F3B7B747D989

P50

Q51994063-47147638-E0F7-4F6D-8312-D849EAB685FB

P577

Q51994063-09DF8765-14E4-448D-8A1B-D14C05C24B54

P5875

Q51994063-F7FC04A5-6CC6-4A47-9790-3B7E24809060

P698

Q51994063-9417F6AE-028D-4C06-BE34-A4F17D83D931

P356

AJPHEART.00447.2006

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Inhibition of matrix metallopr ...... a rat model of heart failure.

@en

P2093

Gregory L Brower

http://www.w3.org/2001/XMLSchema#string

Joseph S Janicki

http://www.w3.org/2001/XMLSchema#string

P2860

X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin

Matrix metalloproteinases

Calprotectin inhibits matrix metalloproteinases by sequestration of zinc

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study

Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.

The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries.

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

Endothelial cell regulation of matrix metalloproteinases.

P304

H3057-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00447.2006

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6497616

http://www.w3.org/2001/XMLSchema#string

P698

17308006

http://www.w3.org/2001/XMLSchema#string